{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:01:58Z","timestamp":1790787718893,"version":"4.1.0"},"reference-count":128,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Cardiogenic shock (CS) is a state of decreased cardiac output leading to systemic hemodynamic collapse and potential end-organ damage with an elevated risk of mortality. CS represents a heterogenous disease state with varying etiologies, severities, and hemodynamics. Several attempts have been made to characterize CS, including the Society of Cardiovascular Angiography &amp;amp; Interventions shock classification (SCAI), the American Heart Association (AHA) hemodynamic phenotypes, as well as other groups defining shock by underlying clinical factors and pathophysiology. Here, we review cardiometabolic shock, a complex and severe form of CS characterized by severe lactic acidosis and metabolic derangement, systemic inflammation with ischemia\/reperfusion injury, persistent vasodilation despite hemodynamic support, and right heart failure, culminating in progressive end-organ failure and a downward spiral of cardiovascular instability. Understanding the components of pathophysiology underlying cardiometabolic shock may help to establish more accurate diagnosis and instituting prompt therapy in the management of this grave cardiac illness. The emerging roles of nitric oxide synthase inhibition, antioxidants, anti-inflammatory agents, proteomics, and artificial intelligence are discussed. Further studies are needed to fully understand cardiometabolic shock and to develop specific effective therapeutic targets.<\/jats:p>","DOI":"10.3389\/fcvm.2025.1653306","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:27:12Z","timestamp":1759123632000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Cardiometabolic shock: understanding the final turns of the downward spiral"],"prefix":"10.3389","volume":"12","author":[{"given":"Tobin","family":"Mathew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1161\/CIRCULATIONAHA.106.613596","article-title":"Cardiogenic shock: current concepts and improving outcomes","volume":"117","author":"Reynolds","year":"2008","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3109\/17482941.2010.523705","article-title":"Cardiogenic shock: the role of inflammation","volume":"12","author":"Shpektor","year":"2010","journal-title":"Acute Card Care"},{"key":"B3","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3390\/cells14110808","article-title":"Role of ischemia\/reperfusion and oxidative stress in shock state","volume":"14","author":"V\u00e1zquez-Gal\u00e1n","year":"2025","journal-title":"Cells"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1001\/archinte.165.14.1643","article-title":"Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock","volume":"165","author":"Kohsaka","year":"2005","journal-title":"Arch Intern Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e011991","DOI":"10.1161\/JAHA.119.011991","article-title":"Cardiogenic shock","volume":"8","author":"Vahdatpour","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"B6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/SHK.0000000000001812","article-title":"Laboratory markers of acidosis and mortality in cardiogenic shock: developing a definition of hemometabolic shock","volume":"57","author":"Jentzer","year":"2022","journal-title":"Shock"},{"key":"B7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.4330\/wjc.v7.i8.483","article-title":"Clinical significance of lactate in acute cardiac patients","volume":"7","author":"Lazzeri","year":"2015","journal-title":"World J Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"7190943","DOI":"10.1155\/2016\/7190943","article-title":"Alternative interventions to prevent oxidative damage following ischemia\/reperfusion","volume":"2016","author":"Rodr\u00edguez-Lara","year":"2016","journal-title":"Oxid Med Cell Longevity"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3614303","DOI":"10.1155\/2018\/3614303","article-title":"The renin-angiotensin-aldosterone system as a therapeutic target in late injury caused by ischemia-reperfusion","volume":"2018","author":"Rodr\u00edguez-Lara","year":"2018","journal-title":"Int J Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"7639","DOI":"10.1038\/s41598-020-64702-0","article-title":"Cardiogenic shock elicits acute inflammation, delayed eosinophilia, and depletion of immune cells in most severe cases","volume":"10","author":"Cuinet","year":"2020","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00392-011-0403-3","article-title":"Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock","volume":"101","author":"Prondzinsky","year":"2012","journal-title":"Clin Res Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association","volume":"136","author":"van Diepen","year":"2017","journal-title":"Circulation"},{"key":"B13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/ccd.28329","article-title":"SCAI Clinical expert consensus statement on the classification of cardiogenic shock","volume":"94","author":"Baran","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e020085","DOI":"10.1161\/JAHA.120.020085","article-title":"Phenotyping cardiogenic shock","volume":"10","author":"Zweck","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B15","doi-asserted-by":"publisher","first-page":"103013","DOI":"10.1016\/j.eclinm.2024.103013","article-title":"Identifying biomarker-driven subphenotypes of cardiogenic shock: analysis of prospective cohorts and randomized controlled trials","volume":"79","author":"Soussi","year":"2025","journal-title":"EClinicalMedicine"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1016\/j.jacc.2019.07.077","article-title":"Cardiogenic shock classification to predict mortality in the cardiac intensive care unit","volume":"74","author":"Jentzer","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s13054-020-02950-2","article-title":"Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019\u2014 results from a systematic review and meta-analysis","volume":"24","author":"Bauer","year":"2020","journal-title":"Critical Care"},{"key":"B18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13054-019-2528-0","article-title":"Trends in sepsis mortality over time in randomised sepsis trials: a systematic literature review and meta-analysis of mortality in the control arm, 2002\u20132016","volume":"23","author":"Luhr","year":"2019","journal-title":"Crit Care"},{"key":"B19","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3238\/arztebl.2018.0757","article-title":"The Nomenclature, definition and distinction of types of shock","volume":"115","author":"Standl","year":"2018","journal-title":"Dtsch Arztebl Int"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/ccd.30103","article-title":"Validation of cardiogenic shock phenotypes in a mixed cardiac intensive care unit population","volume":"99","author":"Jentzer","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e024932","DOI":"10.1161\/JAHA.121.024932","article-title":"Association between the acidemia, lactic acidosis, and shock severity with outcomes in patients with cardiogenic shock","volume":"11","author":"Jentzer","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s00018-018-2995-5","article-title":"Immune responses in cardiac repair and regeneration: a comparative point of view","volume":"76","author":"Lai","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.niox.2024.11.007","article-title":"Nitric oxide and mitochondrial function in cardiovascular diseases","volume":"154","author":"Li","year":"2025","journal-title":"Nitric Oxide"},{"key":"B24","doi-asserted-by":"publisher","first-page":"510","DOI":"10.2174\/1389203723666220823151326","article-title":"Structure, distribution, regulation, and function of splice variant isoforms of nitric oxide synthase family in the nervous system","volume":"23","author":"Hosseini","year":"2022","journal-title":"Curr Protein Pept Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0005-2728(99)00031-6","article-title":"Nitric oxide in septic shock","volume":"1411","author":"Titheradge","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"B26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0735-1097(98)00270-8","article-title":"Production of oxidative products of nitric oxide in infarcted human heart","volume":"32","author":"Akiyama","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2012","journal-title":"Eur Heart J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.3390\/ijms19092605","article-title":"Role of nitric oxide in the cardiovascular and renal systems","volume":"19","author":"Ahmad","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1161\/01.CIR.0000075927.67673.F2","article-title":"Cardiogenic shock complicating acute myocardial infarction","volume":"107","author":"Hochman","year":"2003","journal-title":"Circulation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1161\/hh1601.094993","article-title":"Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction","volume":"89","author":"Sam","year":"2001","journal-title":"Circ Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0195-668X(03)00193-3","article-title":"LINCS: l-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study","volume":"24","author":"Cotter","year":"2003","journal-title":"Eur Heart J"},{"key":"B32","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/cvr\/cvq373","article-title":"Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo","volume":"89","author":"Loukili","year":"2011","journal-title":"Cardiovasc Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1001\/jama.297.15.joc70035","article-title":"Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial","volume":"297","author":"Alexander","year":"2007","journal-title":"JAMA"},{"key":"B34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0899-5885(18)30816-5","article-title":"Pathophysiology of shock","volume":"2","author":"Houston","year":"1990","journal-title":"Crit Care Nurs Clin North Am"},{"key":"B35","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nm1231","article-title":"Thromboxane A2 and prostaglandin F2alpha mediate inflammatory tachycardia","volume":"11","author":"Takayama","year":"2005","journal-title":"Nat Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1365-2044.2007.05371.x","article-title":"Metabolic acidosis in the critically ill: part 2. Causes and treatment","volume":"63","author":"Morris","year":"2008","journal-title":"Anaesthesia"},{"key":"B37","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13054-015-0896-7","article-title":"Hemodynamic consequences of severe lactic acidosis in shock states: from bench to bedside","volume":"19","author":"Kimmoun","year":"2015","journal-title":"Crit Care"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1098\/rsta.2006.1763","article-title":"Acidosis in models of cardiac ventricular myocytes","volume":"364","author":"Crampin","year":"2006","journal-title":"Philos Trans A Math Phys Eng Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"H20","DOI":"10.1152\/ajpheart.1988.254.1.H20","article-title":"Mechanism of diminished contractile response to catecholamines during acidosis","volume":"254","author":"Marsh","year":"1988","journal-title":"Am J Physiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e1486","DOI":"10.1096\/fba.2024-00180","article-title":"GPCR Dimerization: drug discovery aspects and targets in renin-angiotensin systems","volume":"7","author":"Faisal","year":"2025","journal-title":"FASEB BioAdvances"},{"key":"B41","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/FJC.0000000000001213","article-title":"Adrenal G protein-coupled receptors and the failing heart: a long-distance, yet intimate affair","volume":"80","author":"Borges","year":"2022","journal-title":"J Cardiovasc Pharmacol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1016\/j.molcel.2024.10.017","article-title":"Structures and pH-dependent dimerization of the sevenless receptor tyrosine kinase","volume":"84","author":"Cerutti","year":"2024","journal-title":"Mol Cell"},{"key":"B43","doi-asserted-by":"publisher","first-page":"18823","DOI":"10.1038\/s41598-021-98397-8","article-title":"Clinical impact of visually assessed right ventricular dysfunction in patients with septic shock","volume":"11","author":"Hiraiwa","year":"2021","journal-title":"Sci Rep"},{"key":"B44","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3389\/fphys.2020.00224","article-title":"Effects of hypoxia and acidosis on cardiac electrophysiology and hemodynamics. Is NHE-inhibition by cariporide still advantageous?","volume":"11","author":"Salameh","year":"2020","journal-title":"Front Physiol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e4297","DOI":"10.7759\/cureus.4297","article-title":"Bicarbonate therapy for critically ill patients with metabolic acidosis: a systematic review","volume":"11","author":"Ghauri","year":"2019","journal-title":"Cureus"},{"key":"B46","doi-asserted-by":"publisher","first-page":"537","DOI":"10.4103\/ijccm.IJCCM_167_17","article-title":"Hemodialysis for lactic acidosis","volume":"21","author":"Karthiraj","year":"2017","journal-title":"Indian J Crit Care Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/ckj\/sfv045","article-title":"Lactate clearance and metabolic aspects of continuous high-volume hemofiltration","volume":"8","author":"Cheungpasitporn","year":"2015","journal-title":"Clin Kidney J"},{"key":"B48","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pharmthera.2018.01.001","article-title":"Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities","volume":"186","author":"Ong","year":"2018","journal-title":"Pharmacol Ther"},{"key":"B49","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/cvr\/cvs018","article-title":"The innate immune response in reperfused myocardium","volume":"94","author":"Timmers","year":"2012","journal-title":"Cardiovasc Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1161\/CIRCULATIONAHA.107.740233","article-title":"Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction","volume":"117","author":"Abbate","year":"2008","journal-title":"Circulation"},{"key":"B51","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1161\/01.CIR.99.4.546","article-title":"Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions","volume":"99","author":"Gwechenberger","year":"1999","journal-title":"Circulation"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1161\/ATVBAHA.110.208785","article-title":"C-reactive protein, interleukin 6, fibrinogen and risk of sudden death in European middle-aged men: the PRIME study","volume":"30","author":"Empana","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"R152","DOI":"10.1186\/cc11467","article-title":"Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction","volume":"16","author":"Andri\u00e9","year":"2012","journal-title":"Critical Care"},{"key":"B54","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s12265-020-10078-5","article-title":"Systemic inflammatory burden correlates with severity and predicts outcomes in patients with cardiogenic shock supported by a percutaneous mechanical assist device","volume":"14","author":"Diakos","year":"2021","journal-title":"J Cardiovasc Transl Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/cvr\/cvq078","article-title":"Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice","volume":"87","author":"Kobara","year":"2010","journal-title":"Cardiovasc Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fcvm.2019.00025","article-title":"Neutrophils in post-myocardial infarction inflammation: damage vs. Resolution?","volume":"6","author":"Puhl","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.ahj.2007.06.043","article-title":"Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting","volume":"154","author":"Gibson","year":"2007","journal-title":"Am Heart J"},{"key":"B58","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/SHK.0000000000000993","article-title":"Neutrophil-to-Lymphocyte ratio predicts death in acute-on-chronic liver failure patients admitted to the intensive care unit: a retrospective cohort study","volume":"49","author":"Moreau","year":"2018","journal-title":"Shock"},{"key":"B59","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jcrc.2021.12.005","article-title":"Peripheral blood neutrophil-to-lymphocyte ratio is associated with mortality across the spectrum of cardiogenic shock severity","volume":"68","author":"Jentzer","year":"2022","journal-title":"J Crit Care"},{"key":"B60","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cardfail.2019.01.005","article-title":"The neutrophil-lymphocyte ratio and survival during left ventricular assist device support","volume":"25","author":"Sundararajan","year":"2019","journal-title":"J Card Fail"},{"key":"B61","doi-asserted-by":"publisher","first-page":"627","DOI":"10.14202\/vetworld.2018.627-635","article-title":"The crucial roles of inflammatory mediators in inflammation: a review","volume":"11","author":"Abdulkhaleq","year":"2018","journal-title":"Vet World"},{"key":"B62","volume-title":"Really Essential Medical Immunology","author":"Rabson","year":"2005"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/j.mayocp.2021.04.025","article-title":"Eosinophils in health and disease: a state-of-the-art review","volume":"96","author":"Wechsler","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e0206344","DOI":"10.1371\/journal.pone.0206344","article-title":"Characterization and implications of the dynamics of eosinophils in blood and in the infarcted myocardium after coronary reperfusion","volume":"13","author":"Rios-Navarro","year":"2018","journal-title":"PLoS One"},{"key":"B65","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s00395-011-0232-6","article-title":"Regulatory T cells ameliorate cardiac remodeling after myocardial infarction","volume":"107","author":"Tang","year":"2012","journal-title":"Basic Res Cardiol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"8924","DOI":"10.7150\/thno.47118","article-title":"An emerging role of regulatory T-cells in cardiovascular repair and regeneration","volume":"10","author":"Fung","year":"2020","journal-title":"Theranostics"},{"key":"B67","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00392-013-0656-0","article-title":"The Th17\/treg imbalance in patients with cardiogenic shock","volume":"103","author":"del Rosario Espinoza Mora","year":"2014","journal-title":"Clin Res Cardiol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/ars.2007.9.49","article-title":"Mechanisms of cell death in oxidative stress","volume":"9","author":"Ryter","year":"2007","journal-title":"Antioxid Redox Signal"},{"key":"B69","doi-asserted-by":"publisher","first-page":"326","DOI":"10.21037\/atm.2017.06.27","article-title":"The role of reactive oxygen species in the pathophysiology of cardiovascular diseases and the clinical significance of myocardial redox","volume":"5","author":"Moris","year":"2017","journal-title":"Ann Transl Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/01.fjc.0000432861.55968.a6","article-title":"Heart failure and mitochondrial dysfunction: the role of mitochondrial fission\/fusion abnormalities and new therapeutic strategies","volume":"63","author":"Knowlton","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/cvr\/cvq237","article-title":"Mitochondrial morphology and cardiovascular disease","volume":"88","author":"Ong","year":"2010","journal-title":"Cardiovasc Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","article-title":"Lactate metabolism in human health and disease","volume":"7","author":"Li","year":"2022","journal-title":"Sig Transd Target Ther"},{"key":"B73","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.freeradbiomed.2021.07.040","article-title":"Prognostic value of oxidative stress in patients with acute myocardial infarction complicated by cardiogenic shock: a prospective cohort study","volume":"174","author":"Tomandlova","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jtcvs.2020.10.151","article-title":"Autologous mitochondrial transplantation for cardiogenic shock in pediatric patients following ischemia-reperfusion injury","volume":"162","author":"Guariento","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B75","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/SHK.0000000000000756","article-title":"Infectious complications and immune\/inflammatory response in cardiogenic shock patients: a prospective observational study","volume":"47","author":"Parenica","year":"2017","journal-title":"Shock"},{"key":"B76","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic shock","volume":"341","author":"Hochman","year":"1999","journal-title":"N Engl J Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"e006956","DOI":"10.1161\/CIRCOUTCOMES.120.006956","article-title":"Systemic inflammatory response syndrome is associated with increased mortality across the Spectrum of shock severity in cardiac intensive care patients","volume":"13","author":"Jentzer","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1093\/eurheartj\/ehi389","article-title":"The importance of the gastrointestinal system in the pathogenesis of heart failure","volume":"26","author":"Krack","year":"2005","journal-title":"Eur Heart J"},{"key":"B79","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1388-9842(03)00104-1","article-title":"Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure","volume":"5","author":"Peschel","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"B80","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/SHK.0000000000000798","article-title":"Septic participation in cardiogenic shock: exposure to bacterial endotoxin","volume":"47","author":"Ram\u00edrez","year":"2017","journal-title":"SHOCK"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.chest.2020.09.274","article-title":"Right ventricular dysfunction in early sepsis and septic shock","volume":"159","author":"Lanspa","year":"2021","journal-title":"Chest"},{"key":"B82","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1186\/s13054-020-03345-z","article-title":"Right ventricular failure in septic shock: characterization, incidence and impact on fluid responsiveness","volume":"24","author":"Vieillard-Baron","year":"2020","journal-title":"Critical Care"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/j.chest.2020.12.016","article-title":"Impact of right ventricular dysfunction on short-term and long-term mortality in sepsis: a meta-analysis of 1,373 patients","volume":"159","author":"Vallabhajosyula","year":"2021","journal-title":"Chest"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/cid\/cis783","article-title":"Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation","volume":"55","author":"Schmidt","year":"2012","journal-title":"Clin Infect Dis"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1097\/CCM.0000000000002652","article-title":"Nosocomial infections during extracorporeal membrane oxygenation: incidence, etiology, and impact on Patients\u2019 outcome","volume":"45","author":"Grasselli","year":"2017","journal-title":"Crit Care Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13054-020-03444-x","article-title":"Venoarterial extracorporeal membrane oxygenation induces early immune alterations","volume":"25","author":"Frerou","year":"2021","journal-title":"Crit Care"},{"key":"B87","doi-asserted-by":"publisher","first-page":"563853","DOI":"10.3389\/fcvm.2021.563853","article-title":"Right atrial pressure is associated with outcomes in patient with cardiogenic shock receiving acute mechanical circulatory support","volume":"8","author":"Davila","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B88","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1016\/j.cardfail.2020.09.166","article-title":"Transitions in hemometabolic related cardiogenic shock","volume":"26","author":"Hernandez-Montfort","year":"2020","journal-title":"J Card Fail"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e004905","DOI":"10.1161\/CIRCHEARTFAILURE.118.004905","article-title":"Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest: cardinal considerations for initiation and management","volume":"11","author":"Rao","year":"2018","journal-title":"Circ Heart Fail"},{"key":"B90","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jchf.2020.08.012","article-title":"Complete hemodynamic profiling with pulmonary artery catheters in cardiogenic shock is associated with lower in-hospital mortality","volume":"8","author":"Garan","year":"2020","journal-title":"JACC Heart Fail"},{"key":"B91","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jchf.2018.10.007","article-title":"Heart failure and liver disease: cardiohepatic interactions","volume":"7","author":"Xanthopoulos","year":"2019","journal-title":"JACC Heart Fail"},{"key":"B92","doi-asserted-by":"publisher","first-page":"5","DOI":"10.26574\/maedica.2018.13.1.5","article-title":"Ischemic hepatitis\u2014intercorrelated pathology","volume":"13","author":"Ciobanu","year":"2018","journal-title":"Maedica (Bucur)"},{"key":"B93","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/MCC.0000000000000746","article-title":"Kidney and liver dysfunction in cardiogenic shock","volume":"26","author":"Lassus","year":"2020","journal-title":"Curr Opin Crit Care"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1093\/eurheartj\/eht246","article-title":"Interactions of the heart and the liver","volume":"34","author":"M\u00f8ller","year":"2013","journal-title":"Eur Heart J"},{"key":"B95","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13054-016-1242-4","article-title":"Liver function predicts survival in patients undergoing extracorporeal membrane oxygenation following cardiovascular surgery","volume":"20","author":"Roth","year":"2016","journal-title":"Critical Care"},{"key":"B96","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/MCC.0000000000000628","article-title":"Lactate and other biomarkers as treatment target in cardiogenic shock","volume":"25","author":"Fuernau","year":"2019","journal-title":"Curr Opin Crit Care"},{"key":"B97","doi-asserted-by":"publisher","first-page":"197","DOI":"10.15441\/ceem.15.025","article-title":"The effect of liver disease on lactate normalization in severe sepsis and septic shock: a cohort study","volume":"2","author":"Sterling","year":"2015","journal-title":"Clin Exp Emerg Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0883-9441(99)90002-3","article-title":"Relationship between blood lactate and early hepatic dysfunction in acute circulatory failure","volume":"14","author":"De Jonghe","year":"1999","journal-title":"J Crit Care"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.3390\/jcm9092994","article-title":"The impact of hypoxic hepatitis on clinical outcomes after extracorporeal cardiopulmonary resuscitation","volume":"9","author":"Lee","year":"2020","journal-title":"J Clin Med"},{"key":"B100","first-page":"177","article-title":"Splanchnic circulation and metabolism in patients with acute liver failure","volume":"49","author":"Clemmesen","year":"2002","journal-title":"Dan Med Bull"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"key":"B102","doi-asserted-by":"publisher","first-page":"e007099","DOI":"10.1161\/CIRCHEARTFAILURE.120.007099","article-title":"Invasive hemodynamic assessment and classification of in-hospital mortality risk among patients with cardiogenic shock","volume":"13","author":"Thayer","year":"2020","journal-title":"Circ Heart Fail"},{"key":"B103","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/ejhf.872","article-title":"Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the acute heart failure committee of the heart failure association (HFA) of the European Society of Cardiology (ESC)","volume":"19","author":"Harjola","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"B104","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5414\/CNP88FX14","article-title":"Hemodialysis treatment of cardiorenal syndrome","volume":"88","author":"Leskovar","year":"2017","journal-title":"Clin Nephrol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.jtcvs.2014.05.006","article-title":"Effect of early and intensive continuous venovenous hemofiltration on patients with cardiogenic shock and acute kidney injury after cardiac surgery","volume":"148","author":"Li","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.jchf.2023.05.007","article-title":"Clinical course of patients in cardiogenic shock stratified by phenotype","volume":"11","author":"Zweck","year":"2023","journal-title":"JACC Heart Fail"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1093\/eurheartj\/ehz294","article-title":"Protein-based cardiogenic shock patient classifier","volume":"40","author":"Rueda","year":"2019","journal-title":"Eur Heart J"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.amjcard.2015.07.017","article-title":"Usefulness of Beta2-microglobulin as a predictor of all-cause and nonculprit lesion-related cardiovascular events in acute coronary syndromes (from the PROSPECT study)","volume":"116","author":"M\u00f6ckel","year":"2015","journal-title":"Am J Cardiol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/cc9304","article-title":"Bench-to-bedside review: the role of C1-esterase inhibitor in sepsis and other critical illnesses","volume":"15","author":"Singer","year":"2011","journal-title":"Crit Care"},{"key":"B110","doi-asserted-by":"publisher","first-page":"158","DOI":"10.11909\/j.issn.1671-5411.2022.02.007","article-title":"Translational proteomics in cardiogenic shock: from benchmark to bedside","volume":"19","author":"Iborra-Egea","year":"2022","journal-title":"J Geriatr Cardiol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/ejhf.1600","article-title":"Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial","volume":"22","author":"Takagi","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"B112","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cardfail.2024.03.014","article-title":"High circulating dipeptidyl peptidase 3 predicts mortality and need for organ support in cardiogenic shock: an ancillary analysis of the ACCOST-HH trial","volume":"31","author":"Picod","year":"2025","journal-title":"J Card Fail"},{"key":"B113","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ejhf.1601","article-title":"Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics","volume":"22","author":"Deniau","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"B114","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0735-1097(22)01236-0","article-title":"Targeted proteomic profiling of cardiogenic shock in the cardiac intensive care unit: an analysis from the critical care cardiology trials network (ccctn) registry","volume":"79","author":"Lopes","year":"2022","journal-title":"JACC"},{"key":"B115","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/ehjacc\/zuae068","article-title":"Targeted proteomic profiling of cardiogenic shock in the cardiac intensive care unit","volume":"13","author":"Patel","year":"2024","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"B116","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cels.2021.06.006","article-title":"Artificial intelligence for proteomics and biomarker discovery","volume":"12","author":"Mann","year":"2021","journal-title":"Cell Syst"},{"key":"B117","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1111\/jocs.15934","article-title":"Cardiogenic shock and machine learning: a systematic review on prediction through clinical decision support softwares","volume":"36","author":"Aleman","year":"2021","journal-title":"J Card Surg"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1056\/NEJMoa2312572","article-title":"Microaxial flow pump or standard care in infarct-related cardiogenic shock","volume":"390","author":"M\u00f8ller Jacob","year":"2024","journal-title":"N Engl J Med"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1056\/NEJMoa2307227","article-title":"Extracorporeal life support in infarct-related cardiogenic shock","volume":"389","author":"Thiele","year":"2023","journal-title":"N Engl J Med"},{"key":"B120","doi-asserted-by":"publisher","first-page":"11795468221075064","DOI":"10.1177\/11795468221075064","article-title":"A clinical update on vasoactive medication in the management of cardiogenic shock","volume":"16","author":"Shankar","year":"2022","journal-title":"Clin Med Insights Cardiol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1001\/jama.2021.18323","article-title":"Cardiogenic shock after acute myocardial infarction: a review","volume":"326","author":"Samsky","year":"2021","journal-title":"JAMA"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction","volume":"77","author":"Broch","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"B125","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13063-021-05947-6","article-title":"Low-dose corticosteroid therapy for cardiogenic shock in adults (COCCA): study protocol for a randomized controlled trial","volume":"23","author":"Mekontso Dessap","year":"2022","journal-title":"Trials"},{"key":"B126","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1161\/01.CIR.101.12.1358","article-title":"L-NMMA (a nitric oxide synthase inhibitor) is effective in the treatment of cardiogenic shock","volume":"101","author":"Cotter","year":"2000","journal-title":"Circulation"},{"key":"B128","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40139-019-00196-4","article-title":"Nanotherapies for treatment of cardiovascular disease: a case for antioxidant targeted delivery","volume":"7","author":"Cartaya","year":"2019","journal-title":"Curr Pathobiol Rep"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1653306\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:27:15Z","timestamp":1759123635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1653306\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":128,"alternative-id":["10.3389\/fcvm.2025.1653306"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1653306","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"article-number":"1653306"}}